mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.003 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |